全文获取类型
收费全文 | 324543篇 |
免费 | 29101篇 |
国内免费 | 22888篇 |
专业分类
耳鼻咽喉 | 2983篇 |
儿科学 | 3424篇 |
妇产科学 | 4925篇 |
基础医学 | 39952篇 |
口腔科学 | 5505篇 |
临床医学 | 45297篇 |
内科学 | 49727篇 |
皮肤病学 | 3087篇 |
神经病学 | 18369篇 |
特种医学 | 11987篇 |
外国民族医学 | 213篇 |
外科学 | 33283篇 |
综合类 | 49964篇 |
现状与发展 | 76篇 |
一般理论 | 20篇 |
预防医学 | 19640篇 |
眼科学 | 9573篇 |
药学 | 32834篇 |
334篇 | |
中国医学 | 17448篇 |
肿瘤学 | 27891篇 |
出版年
2024年 | 1011篇 |
2023年 | 5028篇 |
2022年 | 13056篇 |
2021年 | 16362篇 |
2020年 | 12053篇 |
2019年 | 10834篇 |
2018年 | 11428篇 |
2017年 | 9931篇 |
2016年 | 9366篇 |
2015年 | 14376篇 |
2014年 | 17816篇 |
2013年 | 15353篇 |
2012年 | 22842篇 |
2011年 | 25832篇 |
2010年 | 15932篇 |
2009年 | 12258篇 |
2008年 | 17032篇 |
2007年 | 17033篇 |
2006年 | 17061篇 |
2005年 | 16786篇 |
2004年 | 10684篇 |
2003年 | 9772篇 |
2002年 | 8461篇 |
2001年 | 7479篇 |
2000年 | 8285篇 |
1999年 | 9031篇 |
1998年 | 5487篇 |
1997年 | 5511篇 |
1996年 | 4343篇 |
1995年 | 3927篇 |
1994年 | 3215篇 |
1993年 | 2101篇 |
1992年 | 2829篇 |
1991年 | 2417篇 |
1990年 | 2124篇 |
1989年 | 1861篇 |
1988年 | 1564篇 |
1987年 | 1354篇 |
1986年 | 1107篇 |
1985年 | 912篇 |
1984年 | 527篇 |
1983年 | 373篇 |
1982年 | 242篇 |
1981年 | 239篇 |
1980年 | 188篇 |
1979年 | 221篇 |
1978年 | 82篇 |
1977年 | 89篇 |
1974年 | 102篇 |
1973年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
191.
192.
Yanli Song Dong Wang 《中国肿瘤临床(英文版)》2007,4(2):142-144
OBJECTIVE To investigate the effect of neoadjuvant chemotherapy in treatment of Stage Ⅱ breast cancer.
METHODS The data from 113 patients with breast cancer of the same pathologic type in Stage Ⅱ,during the period of 1995 to 2001,were analyzed retrospectively.Among the patients,47 were treated with neoadjuvant chemotherapy,and 66 received no adjuvant therapy before surgery(control group).After the patients of the neoadjuvant chemotherapy group had received 2 courses of chemotherapy with the CMF regimen,the surgical procedure was conducted.
RESULTS Complete remission(CR)was attained in 9 of the 47 cases receiving neoadjuvant chemotherapy and partial remission(PR)was reached for 22 cases.The rate of breast-conserving surgery was enhanced from 22.73%to 46.81%(P〈0.05)in the neoadjuvant treatment group.
There was no difference in the 5-year overall survival(OS)and disease-free survival(DFS)rate between the two groups(P〉0.05),but the 5-year OS and DFS of the cases with clinical tumor remission was higher compared to the control group(P〈0.05).
CONCLUSION Neoadjuvant chemotherapy can enhance the rate of breast conservation for Stage Ⅱ breast cancer and may improve the prognosis of the cases with clinical remission. 相似文献
193.
目的:观察中西医结合治疗狼疮性肾炎的疗效。方法:56例用地塞米松、盐酸氮芥、降纤酶、骁悉及中药治疗。结果:完全缓解42.86%,显著缓解16.07%,部分缓解19.64%,无效21.43%。结论:中西医结合治疗狼疮性肾炎疗效较好。 相似文献
194.
In a genetic epidemiology study of a trait, prior to collecting genotype data the foremost task is to test for familial aggregation and examine heritability. Recently, functional traits have drawn attentions from investigators. Here, to test for familial aggregation of a functional trait in the family studies, a test constructed based on the leading functional principal component of heritability, which is a summary measure of temporal genetic variation in a functional trait, is proposed. The p‐value of the test can be approximated by a permutation procedure given the family structure. The asymptotic distribution of the test statistic is derived. Simulations are carried out to examine the size and the power of the test. The proposed methods are applied to the total cholesterol data in the Framingham Heart Study. Copyright © 2009 John Wiley & Sons, Ltd. 相似文献
195.
目的 对比分析食管癌病例组与对照组血缘亲属食管癌患病风险,并了解食管癌家族中危险亲属人群患病的新线索.方法 采用病例对照研究方法 ,对食管癌病例组及对照组各720例进行逐层分析,以比较两组各血缘亲属父系、母系食管癌患病危险度(OR)的大小及差异.结果 (1)病例组Ⅰ级亲属食管癌患病危险度(1.34%~2.24%)显著高于对照组(0.78%~1.21%)(P<0.01);Ⅰ级亲属中病例组父母亲食管癌患病危险度为6.11%,显著高于对照组父母亲食管癌患病危险度2.97%(P<0O01).(2)以血缘亲属中父系和母系亲属逐层分析可见,病例组父系食管癌患病危险度(0.87%~1.01%)与母系患病危险度(0.50%~0.79%)均显著高于对照组父系食管癌患病危险度(0.53%~0.65%)与母系患病危险度(0.38%~0.47%)(P<0.05).进一步分析显示,病例组父系中男性亲属与母系中女性亲属,即父系中祖父、父亲、叔伯食管癌患病危险度为2.68%与母系中外祖母、母亲、姨的食管癌患病危险度1.91%均显著高于对照组父系中男性亲属食管癌患病危险度1.50%与母系中女性亲属食管癌患病危险度0.92%(P<0.01).结论 山西省食管癌患者血缘亲属发病危险主要是父亲及其兄弟、母亲及其姐妹,其下代患食管癌风险要大. 相似文献
196.
补肾益气逐浊法治疗ABO溶血致习惯性流产的临床研究 总被引:3,自引:0,他引:3
目的观察补肾益气逐浊法治疗ABO溶血所致习惯性流产的临床疗效。方法将152例患者随机分为两组,治疗组98例,用补肾益气逐浊法,选用黄芪、菟丝子及蚕砂颗粒剂口服;对照组54例,口服胸腺肽肠溶胶囊等。结果在降低血清抗体效价方面,治疗组总有效率为95.9%,对照组为51.9%;在妊娠疗效方面,治疗组总有效率为95.9%,对照组为42.1%。治疗组疗效明显优于对照组(P〈0.01)。结论补肾益气浊法治疗ABO溶血所致的习惯性流产疗效显著。 相似文献
197.
Fengxiu Ouyang Binyan Wang Lester M. Arguelles Xiping Xu Jianhua Yang Zhiping Li Liuliu Wang Xue Liu Genfu Tang Houxun Xing Craig Langman Xiaobin Wang 《Archives of osteoporosis》2007,2(1-2):29-43
Summary We prospectively examined bone growth patterns in 894 children aged 6–17 years at the baseline visit, with a 6-year follow-up.
Results show bone “tracking” over a six-year interval and sexual dimorphism of bone attained levels and timing of peak bone
growth. Our findings underscore childhood and adolescence as critical periods for building bone and developing gender differences.
Introduction Bone growth patterns were prospectively examined in 894 Chinese children (496 males), aged 6–17 yrs, from a population-based
twin cohort. Whole-body bone area (BA), bone mineral content (BMC), and bone mineral density (BMD) were measured by DEXA at
baseline and a 6-yr follow-up.
Methods Graphic smoothing plots and generalized estimating equations were used to model bone attained levels, growth, and “tracking”.
Results Attained levels of BMC and BA increased curvilinearly with age. Male attained levels were higher than females after age ∼15 yr,
but BMD was lower between 13–17 yrs (Tanner stage I to IV). In both genders, peak BMC and BMD growth lagged ∼2 yrs behind
peak BA growth, which lagged 2 yrs behind peak height growth. Peak bone growth occurred 1–3 yrs later in males. Over the 6-yr
follow-up, all bone measurements “tracked”, but “shifting” across ranks also occurred, and baseline tertile ranking influenced
bone growth. Females with early menarche had higher attained levels than females with late menarche at age 12–13 yrs.
Conclusion Our findings confirm and expand previous studies on peak bone growth conducted in Caucasian cohorts, particularly sexually
dimorphic and maturational effects. The significant “tracking” of bone measurements in this 6-yr follow-up study underscores
the importance that osteoporosis prevention should begin in childhood and adolescence.
Fengxiu Ouyang and Binyan Wang contributed equally to this article.
Source(s) of support: This study is supported in part by grant R01 HD049059, R01 HL0864619 and R01 AR045651 from the National
Institute of Health and by the Food Allergy Project. 相似文献
198.
John Jenn-Yenn Lu Chi-Chia Cheng Shieu-Ming Chou Chang-Bor Hor Yi-Chen Yang Hsiang-Ling Wang 《Vaccine》2009
The first universal hepatitis B vaccination program for newborns in the world was launched in Taiwan in July 1984. Most studies on the effectiveness of hepatitis B vaccination focused on the seroprevalence of HBs Ag among children under 14 years old. Only few studies focused on the seropositivity of anti-HBs among adolescents aged 15–18 years old. The present study aimed to evaluate the impact of the nationwide hepatitis B vaccination program on the immunity to HBV infection and the necessity of boost among adolescents. In this study including eight annual seroprevalence surveys from 2000 to 2007, 2342 college entrants (1589 15-year-olds in group I and 753 18-year-olds in group II) and 1851 university freshmen (18-year-olds in group III) participated. Subjects identified anti-HBs, HBs Ag and anti-HBc negative were given boost three doses of HBV vaccine. The HBs Ag seroprevalence was 11.6%, 3.5% and 1.0% for participants who were born before 1984, 1984–1986 and after 1986. The anti-HBs-seropositive rates were significantly higher in group II (83.1%) than in group I (53.0%) and group III (53.5%). All 572 participants who were seronegative for anti-HBs, HBs Ag and anti-HBc became anti-HBs-seropositive after catch-up vaccination. It is concluded that the anti-HBs-seropositive rate decreased to 50% in 15 years after vaccination, and boost vaccination was 100% effective. The necessity and age for boost among anti-HBs negative adolescents and the timing of the first immunization should be further evaluated. 相似文献
199.
目的:探讨宫腔镜检查术在辅助生殖技术中应用的重要性。方法:对150例拟行辅助生殖技术的不育妇女行常规宫腔镜检查。结果:宫腔镜150例中47例(31%)有镜下异常,其中:子宫内膜息肉或息肉样增生18例(12%),子宫内膜单纯性增生17例(11%),子宫畸形7例(5%),宫腔粘连狭窄3例(2%),子宫内膜结核1例(0.7%),子宫黏膜下肌瘤或腺肌瘤1例(0.7%)。以宫腔镜诊断为标准,阴道超声诊断敏感性、特异性、阳性预测值、阴性预测值、准确率分别为66%(31/47)、98%(101/103)、94%(31/33)、86%(101/117)、88%(132/150),子宫造影分别为26%(12/47)、100%(95/95)、100%(12/12)、73%(95/130)、75%(107/142)。结论:宫腔镜检查术具有良好的可接受性和准确性,应作为辅助生殖技术前的常规检查。 相似文献
200.
目的探讨经乙状窦后入路显微手术治疗桥小脑角占位性病变引起的继发性三叉神经痛的疗效。方法回顾分析我院2000年10月~2006年7月37例继发性三叉神经痛的临床资料,其中胆脂瘤18例,脑膜瘤8例,听神经瘤6例,三叉神经鞘瘤5例,均经乙状窦后入路显微手术切除肿瘤。结果肿瘤全切23例,次全切除10例,部分切除4例。35例疼痛症状消失(32例立即消失,3例术后2个月消失),随访3个月~5年无复发;2例无效。发生暂时性面瘫6例,面部麻木6例,无颅内感染及脑脊液漏。结论经乙状窦后入路显微手术是治疗继发性三叉神经痛安全有效的方法。 相似文献